摘要
慢性阻塞性肺疾病是临床常见的呼吸系统疾病,发病率及死亡率正逐年升高。中医临床常根据其喘、咳以及呼吸困难等主要症状将其归于肺胀、喘证等范畴论治。中医理论认为气血阴阳乃人身之根本,而该病病在气虚,阳虚,气虚无以行水,阳虚无以化水,水湿内蕴成痰而发病,故言本虚标实乃该病发病之基本病机。而四逆汤乃温阳补阳之基础方,再加之重剂黄芪功专补气,临床常常被用来改善慢阻肺症状,疗效颇佳。作者从本虚标实探讨四逆汤加重剂黄芪治疗慢阻肺的理论机制并举隅临床验案,以飨同道。
Chronic obstructive pulmonary disease(COPD)is a common respiratory disease in clinic.Its morbidity and mortality are increasing year by year.The main symptoms of asthma,cough and dyspnea in traditional Chinese medicine(TCM)are often classified into the categories of pulmonary distention and asthma syndrome.Traditional Chinese medicine theory holds that Qi,blood,Yin and yang are the root of human body,and the disease is caused by Qi deficiency,Yang deficiency and Qi deficiency,which can not disperse water,Yang deficiency can not evaporate water,and water stops gathering.Therefore,the cause of COPD is“Benxu Biaoshi”Sini decoction is the basic prescription for warming yang and tonifying Yang,combined with Huangqi Gong,a heavy agent for tonifying Qi.It is often used to improve the symptoms of COPD in clinic,and its curative effect is quite good.This article discusses the theoretical mechanism of Sini decoction aggravating agent Astragalus membranaceus in the treatment of chronic obstructive pulmonary disease(COPD)and cites clinical cases in order to share the same experience.
作者
董敏
王兰娣
李兴芳
DONG Min;WANG Landi;LI Xingfang(Gansu Provincial Hospital of Traditional Chinese Medicine,Gansu Lanzhou 730050,China)
出处
《中医药临床杂志》
2020年第4期664-666,共3页
Clinical Journal of Traditional Chinese Medicine
基金
甘肃省重点研发计划项目:黄芪四逆汤治疗慢性阻塞性肺疾病的临床药效对照研究(NO.18YF1FA042)。
关键词
慢阻肺
本虚标实
重剂黄芪
四逆汤
COPD
Benxu Biaoshi
Heavy dose of Astragalus membranaceus
Sini secoction
